Mesenchymal stromal cells as a salvage treatment for confirmed acute respiratory distress syndrome: preliminary data from a single-arm study

Intensive Care Med. 2020 Oct;46(10):1944-1947. doi: 10.1007/s00134-020-06122-2. Epub 2020 Jun 8.
No abstract available

Publication types

  • Letter

MeSH terms

  • COVID-19*
  • Humans
  • Mesenchymal Stem Cells*
  • Preliminary Data
  • Respiratory Distress Syndrome* / therapy
  • Salvage Therapy